Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 6,650.00
-100.00 (-1.48%)
Sep 18, 2025, 2:40 PM KST
Komipharm International Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 54,812 | 58,779 | 42,647 | 39,801 | 35,847 | 37,160 | Upgrade |
Other Revenue | - | - | - | - | -0 | - | Upgrade |
| 54,812 | 58,779 | 42,647 | 39,801 | 35,847 | 37,160 | Upgrade | |
Revenue Growth (YoY) | 6.68% | 37.83% | 7.15% | 11.03% | -3.53% | 4.71% | Upgrade |
Cost of Revenue | 36,942 | 37,146 | 30,120 | 28,485 | 24,741 | 23,857 | Upgrade |
Gross Profit | 17,870 | 21,633 | 12,527 | 11,316 | 11,107 | 13,303 | Upgrade |
Selling, General & Admin | 11,717 | 11,741 | 10,459 | 10,004 | 9,127 | 9,907 | Upgrade |
Research & Development | 1,872 | 2,466 | 5,945 | 2,536 | 5,117 | 3,266 | Upgrade |
Other Operating Expenses | 36.01 | 236.76 | 243.5 | 251.86 | 220.89 | 215.79 | Upgrade |
Operating Expenses | 14,461 | 15,440 | 18,800 | 15,119 | 16,397 | 15,478 | Upgrade |
Operating Income | 3,409 | 6,193 | -6,273 | -3,804 | -5,291 | -2,175 | Upgrade |
Interest Expense | -3,093 | -3,206 | -2,552 | -2,216 | -1,657 | -1,549 | Upgrade |
Interest & Investment Income | 854.87 | 707.18 | 678.36 | 227.68 | 140.21 | 165.33 | Upgrade |
Currency Exchange Gain (Loss) | -264.38 | 1,109 | 235.11 | 474.93 | 1,129 | -217.15 | Upgrade |
Other Non Operating Income (Expenses) | -2,165 | 2,781 | 2,106 | 940.07 | 51.94 | -447.5 | Upgrade |
EBT Excluding Unusual Items | -1,259 | 7,585 | -5,805 | -4,377 | -5,626 | -4,224 | Upgrade |
Gain (Loss) on Sale of Investments | -58.65 | -123.27 | 248.7 | - | 13.59 | 122.52 | Upgrade |
Gain (Loss) on Sale of Assets | 9,074 | 9,073 | 64.42 | -2.43 | 0.81 | 144.51 | Upgrade |
Asset Writedown | -1,845 | -1,845 | -247.4 | -3,100 | -323 | - | Upgrade |
Pretax Income | 5,752 | 14,690 | -5,739 | -7,480 | -5,934 | -3,957 | Upgrade |
Income Tax Expense | - | - | 171.15 | - | - | - | Upgrade |
Earnings From Continuing Operations | 5,752 | 14,690 | -5,911 | -7,480 | -5,934 | -3,957 | Upgrade |
Minority Interest in Earnings | -1,649 | -1,577 | 1,932 | 965.91 | 1,475 | 1,141 | Upgrade |
Net Income | 4,103 | 13,113 | -3,979 | -6,514 | -4,459 | -2,816 | Upgrade |
Net Income to Common | 4,103 | 13,113 | -3,979 | -6,514 | -4,459 | -2,816 | Upgrade |
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | 70 | Upgrade |
Shares Outstanding (Diluted) | 70 | 70 | 70 | 70 | 70 | 70 | Upgrade |
Shares Change (YoY) | 0.50% | -0.66% | -0.18% | 0.01% | 0.09% | 0.37% | Upgrade |
EPS (Basic) | 58.94 | 188.17 | -56.72 | -92.68 | -63.45 | -40.10 | Upgrade |
EPS (Diluted) | 58.53 | 188.00 | -57.00 | -93.00 | -63.64 | -40.10 | Upgrade |
Free Cash Flow | 2,366 | 7,802 | -3,437 | -2,656 | -2,069 | -1,631 | Upgrade |
Free Cash Flow Per Share | 33.99 | 111.95 | -48.99 | -37.78 | -29.45 | -23.22 | Upgrade |
Gross Margin | 32.60% | 36.80% | 29.37% | 28.43% | 30.98% | 35.80% | Upgrade |
Operating Margin | 6.22% | 10.54% | -14.71% | -9.56% | -14.76% | -5.85% | Upgrade |
Profit Margin | 7.49% | 22.31% | -9.33% | -16.37% | -12.44% | -7.58% | Upgrade |
Free Cash Flow Margin | 4.32% | 13.27% | -8.06% | -6.67% | -5.77% | -4.39% | Upgrade |
EBITDA | 6,460 | 9,293 | -2,744 | 22.34 | -1,708 | 1,565 | Upgrade |
EBITDA Margin | 11.79% | 15.81% | -6.43% | 0.06% | -4.76% | 4.21% | Upgrade |
D&A For EBITDA | 3,051 | 3,100 | 3,529 | 3,826 | 3,582 | 3,740 | Upgrade |
EBIT | 3,409 | 6,193 | -6,273 | -3,804 | -5,291 | -2,175 | Upgrade |
EBIT Margin | 6.22% | 10.54% | -14.71% | -9.56% | -14.76% | -5.85% | Upgrade |
Advertising Expenses | - | 408.7 | 256.75 | 227.89 | 206.18 | 153.12 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.